Target intelligence / Profile preview

LAMP5 antisense RNA 1 (LAMP5-AS1)

Target
LAMP5-AS1
Molecular classification
Long noncoding RNA (lncRNA), Other
01

Overview

LAMP5 antisense RNA 1 (LAMP5-AS1) is a long noncoding RNA transcribed from the antisense strand of the LAMP5 gene on chromosome 20. It is highly expressed in MLL-rearranged (mixed-lineage leukemia) cells and directly interacts with the lysine methyltransferase DOT1L to promote global H3K79 methylation, upregulating genes that maintain leukemia stemness and block differentiation. LAMP5-AS1 also regulates expression of the LAMP5 protein by recruiting the DOT1L complex to the LAMP5 locus, thereby inhibiting autophagic degradation of oncogenic MLL fusion proteins. High LAMP5-AS1 expression is a diagnostic and prognostic biomarker in MLL-rearranged leukemia. Its function is primarily epigenetic regulation in the context of oncogenesis, and it is under investigation as a potential therapeutic target in hematological malignancies. No direct interacting drugs are currently known, but its inhibition in cell and animal models impairs leukemia progression and promotes differentiation.

Other names
LAMP5-AS1lncRNA LAMP5-AS1LAMP5 antisense lncRNA
02

Mechanism of action

LAMP5-AS1 binds to and modulates the methyltransferase activity of DOT1L, enhancing global H3K79 methylation and facilitating the expression of genes critical to leukemia cell stemness. LAMP5-AS1 activates LAMP5 expression through direct interaction with DOT1L at the LAMP5 locus, which in turn inhibits autophagic degradation of oncogenic MLL fusion proteins.

03

Biological functions

Regulation of gene expressionEpigenetic modificationRegulation of self-renewal and differentiation in leukemia cellsRegulation of autophagy
04

Disease associations

Cancer (particularly mixed-lineage leukemia, MLL-rearranged leukemia)Other (potential additional roles in other cancers, but currently best described in MLL leukemia)
05

Safety considerations

None specifically reported for LAMP5-AS1 targeting, but targeting lncRNAs can pose risks of off-target effects and impact on epigenetic regulation in normal tissues.
06

Biomarkers

Elevated LAMP5-AS1 expression is a biomarker for MLL-rearranged leukemia, distinguishing it from MLL-wildtype leukemias and healthy controls.LAMP5-AS1 levels correlate with disease status: they are higher at diagnosis and decrease in remission.

Beyond the preview

Go deeper on LAMP5 antisense RNA 1 (LAMP5-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LAMP5 antisense RNA 1 (LAMP5-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call